Covaxin booster dose increases immune response by 40 times: Bharat Biotech Rahul Verma21 July 2022 6:00 PM ISTBharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine, has proven to be...
Bharat Biotech says Covaxin booster dose increases immune response by 40 times Ruchika Sharma21 July 2022 12:30 PM ISTHyderabad: Bharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine, has...
Covaxin demonstrates robust safety and immunogenicity in children 2-18 years, says Bharat Biotech Ruchika Sharma17 Jun 2022 12:46 PM ISTCOVAXIN is a ready to use liquid vaccine, stored at 2-8°C, with 12 months shelf life and multi dose vial policy.
USFDA removes clinical hold on Covaxin trial: Ocugen Ruchika Sharma24 May 2022 12:33 PM ISTCOVAXIN is listed by the World Health Organization (WHO) as authorized for emergency use.
USFDA lifts clinical hold on Covaxin new drug application: Ocugen Ruchika Sharma19 Feb 2022 12:01 PM ISTMalvern: Ocugen, Inc. has recently announced that the U.S. Food and Drug Administration (USFDA) has lifted its clinical hold on the Company's...
USFDA issues clinical hold on Covaxin new drug application: Ocugen Ruchika Sharma29 Nov 2021 11:30 AM ISTMalvern: Ocugen, Inc. has recently announced that the U.S. Food and Drug Administration (FDA) has issued a clinical hold on the Company's...
Bharat Biotech US partner Ocugen files for clinical trials of Covaxin Ruchika Sharma28 Oct 2021 2:16 PM ISTMalvern: Ocugen, Inc., has announced that the company has submitted an Investigational New Drug application (IND) with the U.S. Food and Drug...
CDSCO panel emergency use nod to Covaxin for children aged 2-18 years Ruchika Sharma12 Oct 2021 3:23 PM ISTNew Delhi: An expert panel of India's Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin...
Data from 25,800 participants shows 81% efficacy of COVAXIN in Phase III trial: Bharat Biotech Ruchika Sharma4 March 2021 1:50 PM ISTHyderabad: Bharat Biotech has recently announced the first interim analysis of its BBV152 (COVAXIN). The whole virion inactivated COVID-19 vaccine...
COVID Vaccine: Bharat Biotech gets CDSCO nod to conduct Phase II Trials MD Bureau7 Sept 2020 11:30 AM ISTThese trials of BBV152 coronavirus vaccine or Covaxin will be conducted on 380 participants, who will have to be screened for 4 days after they...
